A review of methods used in assessing non-serious adverse drug events in observational studies among type 2 diabetes mellitus patients

Clinical drug trials are often conducted in selective patient populations, with relatively small numbers of patients, and a short duration of follow-up. Observational studies are therefore important for collecting additional information on adverse drug events (ADEs). Currently, there is no guidance...

Descripción completa

Detalles Bibliográficos
Autores principales: Hakobyan, Liana, Haaijer-Ruskamp, Flora M, de Zeeuw, Dick, Dobre, Daniela, Denig, Petra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198877/
https://www.ncbi.nlm.nih.gov/pubmed/21958008
http://dx.doi.org/10.1186/1477-7525-9-83

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198877/
https://www.ncbi.nlm.nih.gov/pubmed/21958008
http://dx.doi.org/10.1186/1477-7525-9-83

Ejemplares similares